EQT enters exclusive negotiations to acquire Schülke
EQT has entered exclusive negotiations to acquire Germany-based hygiene products producer Schülke, following a sale process that saw the asset becoming increasingly attractive due to the impact of the coronavirus.
The deal remains subject to competition authority clearance and a final agreement between the parties.
The process is one of very few to be affected positively by the Covid-19 outbreak. The vendor, Air Liquide, ended up pushing the final bid deadline back to 23 April, Mergermarket reported on 31 March. Ardian, EQT and PAI Partners ultimately advanced into the final round.
The company was originally marketed based on an EBITDA of €50-70m, according to Debtwire – this was raised to €75m as the coronavirus outbreak boosted the company's trading. The company is expected to see revenues increase during and following the outbreak due to increased consumer consciousness on hygiene, given that it sells hand sanitiser. It currently reports revenues of €335m.
EQT will deploy equity via EQT VIII, which held a final close in February 2018 on €10.75bn. Following the transaction, the fund will be 70-75% deployed, according to a statement.
The GP aims to strengthen the company's position in existing markets as well as to expand to new ones, according to a statement. It will also focus on R&D for new products, and support the company during the coronavirus outbreak by increasing its production of disinfectants.
Debt
Debtwire reported that the GP has taken a unitranche facility from HPS to finance the acquisition, citing an EQT spokesperson. Debt quantum through unitranche was pitched at around €400m, implying leverage of 5x-5.5x based on an EBITDA of €70-80m, according to Debtwire.
Company
Schülke was founded in 1989 and is based in Norderstedt. It has been a subsidiary of France-based Air Liquide since 1996. It employs 1,250 people.
People
EQT – Matthias Wittkowski (partner).
Schülke – Christian Last (CEO).
Advisers
Equity – Goldman Sachs (corporate finance); Deloitte (corporate finance); Freshfields Bruckhaus Deringer (legal).
Vendor – JP Morgan (M&A).
More on Buyouts
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Main Capital’s Assessio to be sold to Pollen Street
Recruitment software company tripled in revenue under Main Capital’s ownership
Exponent divests ‘significant' stake in Meadow to Canadian investor
Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater